Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients

NCT01559103 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: MEDI5117
BIOLOGICAL: MEDI5117 Placebo

Sponsor

Novo Nordisk A/S